Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, Follicular | 12 | 2024 | 459 | 3.070 |
Why?
|
Thymus Neoplasms | 4 | 2024 | 270 | 1.350 |
Why?
|
Thymoma | 3 | 2023 | 185 | 1.250 |
Why?
|
Lymphoma, B-Cell | 4 | 2022 | 943 | 0.820 |
Why?
|
Translocation, Genetic | 3 | 2023 | 1393 | 0.660 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2020 | 82 | 0.660 |
Why?
|
Splenomegaly | 1 | 2020 | 192 | 0.640 |
Why?
|
Lymphoma, T-Cell | 6 | 2024 | 308 | 0.610 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 3 | 2025 | 1434 | 0.550 |
Why?
|
Parotid Gland | 1 | 2018 | 177 | 0.550 |
Why?
|
Burkitt Lymphoma | 2 | 2025 | 338 | 0.550 |
Why?
|
Syphilis | 1 | 2018 | 243 | 0.490 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2016 | 180 | 0.480 |
Why?
|
Lymphoma | 4 | 2022 | 1896 | 0.430 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2017 | 335 | 0.430 |
Why?
|
Gene Rearrangement | 3 | 2020 | 1143 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2021 | 1409 | 0.390 |
Why?
|
Skin Neoplasms | 6 | 2022 | 5824 | 0.390 |
Why?
|
Infectious Mononucleosis | 1 | 2012 | 133 | 0.380 |
Why?
|
Mutation | 11 | 2023 | 30184 | 0.380 |
Why?
|
Chromosomes, Human, Pair 11 | 3 | 2025 | 412 | 0.380 |
Why?
|
Myasthenia Gravis | 1 | 2013 | 214 | 0.350 |
Why?
|
Myositis | 1 | 2013 | 270 | 0.340 |
Why?
|
Dendritic Cell Sarcoma, Follicular | 2 | 2021 | 30 | 0.320 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1489 | 0.320 |
Why?
|
Immunophenotyping | 3 | 2023 | 1865 | 0.310 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2021 | 195 | 0.310 |
Why?
|
Scapula | 1 | 2010 | 174 | 0.310 |
Why?
|
Histiocytosis, Langerhans-Cell | 1 | 2010 | 169 | 0.300 |
Why?
|
Endometrial Neoplasms | 1 | 2016 | 1378 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2021 | 190 | 0.270 |
Why?
|
Bone Diseases | 1 | 2010 | 411 | 0.270 |
Why?
|
Diagnosis, Differential | 7 | 2020 | 12949 | 0.260 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1415 | 0.250 |
Why?
|
Sarcoma, Myeloid | 2 | 2018 | 52 | 0.250 |
Why?
|
Lymph Nodes | 3 | 2020 | 3451 | 0.240 |
Why?
|
Biopsy | 5 | 2018 | 6754 | 0.230 |
Why?
|
Edema | 3 | 2017 | 760 | 0.210 |
Why?
|
Erythrocytes, Abnormal | 1 | 2023 | 122 | 0.210 |
Why?
|
Canaries | 1 | 2002 | 6 | 0.200 |
Why?
|
Leg | 2 | 2018 | 1080 | 0.200 |
Why?
|
Cell Nucleus | 2 | 2023 | 2862 | 0.200 |
Why?
|
Neoplasms, Multiple Primary | 2 | 2018 | 584 | 0.190 |
Why?
|
Neoplasm Proteins | 4 | 2018 | 3593 | 0.190 |
Why?
|
Myeloproliferative Disorders | 2 | 2021 | 615 | 0.190 |
Why?
|
Dendritic Cells | 3 | 2021 | 2746 | 0.180 |
Why?
|
Lectins, C-Type | 1 | 2024 | 592 | 0.180 |
Why?
|
Oncogenes | 2 | 2023 | 1232 | 0.180 |
Why?
|
HIV-1 | 1 | 2018 | 6944 | 0.170 |
Why?
|
Oncogene Fusion | 1 | 2020 | 84 | 0.170 |
Why?
|
Cell Shape | 2 | 2023 | 372 | 0.170 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2024 | 488 | 0.170 |
Why?
|
In Situ Hybridization, Fluorescence | 3 | 2016 | 2504 | 0.170 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2021 | 125 | 0.160 |
Why?
|
Humans | 53 | 2025 | 765734 | 0.160 |
Why?
|
Chromosome Aberrations | 4 | 2025 | 1774 | 0.160 |
Why?
|
Sarcoma | 2 | 2021 | 1801 | 0.160 |
Why?
|
Hematologic Diseases | 1 | 2023 | 500 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2022 | 13448 | 0.160 |
Why?
|
Cathepsins | 1 | 2020 | 242 | 0.160 |
Why?
|
Thymus Gland | 1 | 2024 | 1260 | 0.160 |
Why?
|
Ribonucleoproteins | 1 | 2021 | 359 | 0.160 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1926 | 0.160 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2023 | 8926 | 0.160 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2021 | 648 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 353 | 0.150 |
Why?
|
Duodenal Neoplasms | 1 | 2018 | 114 | 0.150 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2018 | 52 | 0.150 |
Why?
|
Orotate Phosphoribosyltransferase | 1 | 2017 | 5 | 0.140 |
Why?
|
Orotidine-5'-Phosphate Decarboxylase | 1 | 2017 | 8 | 0.140 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 309 | 0.140 |
Why?
|
Antigen Presentation | 2 | 2020 | 1250 | 0.140 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11007 | 0.140 |
Why?
|
Middle Aged | 23 | 2025 | 222903 | 0.140 |
Why?
|
Mutation, Missense | 2 | 2018 | 2586 | 0.140 |
Why?
|
Skull Neoplasms | 1 | 2018 | 173 | 0.140 |
Why?
|
Exophthalmos | 1 | 2018 | 99 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 2 | 2021 | 1059 | 0.140 |
Why?
|
Sphenoid Bone | 1 | 2018 | 176 | 0.140 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 919 | 0.130 |
Why?
|
Cell Proliferation | 1 | 2012 | 10428 | 0.130 |
Why?
|
rho GTP-Binding Proteins | 1 | 2018 | 280 | 0.130 |
Why?
|
Thiophenes | 1 | 2020 | 569 | 0.130 |
Why?
|
Receptors, IgG | 1 | 2019 | 559 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2018 | 360 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 697 | 0.120 |
Why?
|
Hydronephrosis | 1 | 2017 | 274 | 0.120 |
Why?
|
Chromosomes, Human | 1 | 2017 | 437 | 0.120 |
Why?
|
Genomics | 3 | 2021 | 5924 | 0.120 |
Why?
|
HIV Infections | 2 | 2020 | 17531 | 0.120 |
Why?
|
Neovascularization, Physiologic | 1 | 2002 | 1377 | 0.120 |
Why?
|
Culture Media | 1 | 2017 | 889 | 0.120 |
Why?
|
Thymus Hyperplasia | 1 | 2014 | 32 | 0.120 |
Why?
|
Male | 25 | 2025 | 363585 | 0.110 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2013 | 40 | 0.110 |
Why?
|
Thymectomy | 1 | 2014 | 200 | 0.110 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2018 | 582 | 0.110 |
Why?
|
Tomography, X-Ray | 1 | 2013 | 58 | 0.110 |
Why?
|
Multienzyme Complexes | 1 | 2017 | 663 | 0.110 |
Why?
|
Splenectomy | 1 | 2015 | 390 | 0.110 |
Why?
|
Refractometry | 1 | 2013 | 57 | 0.110 |
Why?
|
Leukemia, B-Cell | 1 | 2013 | 86 | 0.110 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2025 | 8603 | 0.110 |
Why?
|
Smoking | 1 | 2010 | 9077 | 0.110 |
Why?
|
I-kappa B Kinase | 1 | 2014 | 248 | 0.100 |
Why?
|
Back Pain | 1 | 2017 | 544 | 0.100 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2020 | 3640 | 0.100 |
Why?
|
B-Lymphocytes | 2 | 2023 | 4779 | 0.100 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2018 | 975 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 3 | 2021 | 5753 | 0.100 |
Why?
|
Aged | 17 | 2025 | 171050 | 0.100 |
Why?
|
Female | 24 | 2025 | 395961 | 0.100 |
Why?
|
Autopsy | 1 | 2016 | 1011 | 0.100 |
Why?
|
Reed-Sternberg Cells | 1 | 2012 | 78 | 0.100 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59459 | 0.100 |
Why?
|
Face | 1 | 2018 | 1028 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2021 | 2941 | 0.090 |
Why?
|
Lung | 1 | 2010 | 10031 | 0.090 |
Why?
|
Soft Tissue Neoplasms | 1 | 2020 | 1163 | 0.090 |
Why?
|
Immunoglobulin Light Chains | 1 | 2012 | 290 | 0.090 |
Why?
|
Pyrimidines | 2 | 2020 | 3044 | 0.090 |
Why?
|
Uric Acid | 1 | 2017 | 809 | 0.090 |
Why?
|
Radiography | 2 | 2013 | 6917 | 0.090 |
Why?
|
Sulfonamides | 1 | 2020 | 1981 | 0.090 |
Why?
|
Prognosis | 4 | 2023 | 29899 | 0.090 |
Why?
|
Specimen Handling | 1 | 2015 | 703 | 0.090 |
Why?
|
Fever | 1 | 2018 | 1602 | 0.090 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 627 | 0.090 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4423 | 0.080 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10262 | 0.080 |
Why?
|
NF-kappa B | 2 | 2018 | 2486 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3948 | 0.080 |
Why?
|
Body Height | 1 | 2016 | 1561 | 0.080 |
Why?
|
Proto-Oncogene Proteins | 2 | 2020 | 4520 | 0.080 |
Why?
|
Eye | 1 | 2013 | 710 | 0.080 |
Why?
|
Spleen | 1 | 2015 | 2295 | 0.080 |
Why?
|
Adult | 13 | 2021 | 222974 | 0.080 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2012 | 614 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 3794 | 0.080 |
Why?
|
MicroRNAs | 1 | 2025 | 3784 | 0.080 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 1 | 2009 | 77 | 0.070 |
Why?
|
Necrosis | 1 | 2012 | 1613 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2045 | 0.070 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2009 | 428 | 0.070 |
Why?
|
Mitochondria | 1 | 2020 | 3670 | 0.070 |
Why?
|
Pain | 2 | 2013 | 5074 | 0.070 |
Why?
|
Herpesvirus 4, Human | 1 | 2012 | 1078 | 0.070 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 1224 | 0.070 |
Why?
|
Gene Expression Profiling | 2 | 2025 | 9522 | 0.070 |
Why?
|
Signal Transduction | 6 | 2020 | 23589 | 0.060 |
Why?
|
Peptides | 1 | 2018 | 4331 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5693 | 0.060 |
Why?
|
Cough | 1 | 2010 | 597 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2018 | 5781 | 0.060 |
Why?
|
Lymphocyte Activation | 2 | 2018 | 5501 | 0.060 |
Why?
|
Neurons | 2 | 2002 | 9521 | 0.060 |
Why?
|
Infant | 4 | 2018 | 36363 | 0.060 |
Why?
|
Bone Neoplasms | 1 | 2018 | 2564 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5336 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 4 | 2018 | 20667 | 0.060 |
Why?
|
Crohn Disease | 1 | 2018 | 2283 | 0.060 |
Why?
|
Child | 6 | 2021 | 80499 | 0.060 |
Why?
|
Body Weight | 1 | 2016 | 4624 | 0.060 |
Why?
|
Mice | 9 | 2024 | 81792 | 0.060 |
Why?
|
Antigens, CD | 2 | 2013 | 4020 | 0.060 |
Why?
|
Neoplasms, Second Primary | 1 | 2012 | 1048 | 0.060 |
Why?
|
Lymphocytes | 1 | 2012 | 2600 | 0.060 |
Why?
|
Glucocorticoids | 1 | 2013 | 2132 | 0.060 |
Why?
|
Young Adult | 6 | 2020 | 59852 | 0.060 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2024 | 3605 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4763 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2023 | 20120 | 0.050 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 187 | 0.050 |
Why?
|
Survival Rate | 2 | 2018 | 12787 | 0.050 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3818 | 0.050 |
Why?
|
Animals | 11 | 2024 | 168731 | 0.050 |
Why?
|
Myelodysplastic Syndromes | 1 | 2012 | 1403 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 837 | 0.050 |
Why?
|
Plaque, Atherosclerotic | 1 | 2013 | 1530 | 0.050 |
Why?
|
Amino Acid Substitution | 2 | 2018 | 1739 | 0.050 |
Why?
|
Child, Preschool | 2 | 2016 | 42468 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2002 | 324 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2018 | 9594 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 88781 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2002 | 754 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
Endothelial Growth Factors | 1 | 2002 | 680 | 0.040 |
Why?
|
Cell Line, Tumor | 3 | 2024 | 17062 | 0.040 |
Why?
|
Algorithms | 2 | 2018 | 14061 | 0.040 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2020 | 318 | 0.040 |
Why?
|
Age Factors | 1 | 2016 | 18375 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9368 | 0.040 |
Why?
|
Antigens, CD1d | 1 | 2020 | 226 | 0.040 |
Why?
|
Lymphokines | 1 | 2002 | 911 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2002 | 658 | 0.040 |
Why?
|
Imidazolines | 1 | 2018 | 18 | 0.040 |
Why?
|
Inflammation | 1 | 2018 | 10846 | 0.040 |
Why?
|
Africa South of the Sahara | 1 | 2021 | 751 | 0.040 |
Why?
|
Brain | 2 | 2002 | 27178 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2010 | 2084 | 0.040 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2002 | 605 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 18972 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4106 | 0.040 |
Why?
|
Depsipeptides | 1 | 2018 | 95 | 0.040 |
Why?
|
Skin | 2 | 2022 | 4474 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1743 | 0.040 |
Why?
|
Cohort Studies | 3 | 2019 | 41631 | 0.030 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2018 | 234 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2020 | 951 | 0.030 |
Why?
|
Ikaros Transcription Factor | 1 | 2018 | 230 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 2018 | 340 | 0.030 |
Why?
|
Forensic Pathology | 1 | 2016 | 23 | 0.030 |
Why?
|
Automation, Laboratory | 1 | 2017 | 102 | 0.030 |
Why?
|
Venous Thromboembolism | 1 | 2009 | 1882 | 0.030 |
Why?
|
Entropy | 1 | 2017 | 208 | 0.030 |
Why?
|
Postmortem Changes | 1 | 2016 | 119 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1327 | 0.030 |
Why?
|
Receptors, Fc | 1 | 2019 | 536 | 0.030 |
Why?
|
Cell Separation | 1 | 2001 | 1718 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2020 | 1440 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 632 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6487 | 0.030 |
Why?
|
Gender Identity | 1 | 2021 | 766 | 0.030 |
Why?
|
Estrogens | 1 | 2002 | 1529 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13639 | 0.030 |
Why?
|
Disease Progression | 1 | 2012 | 13614 | 0.030 |
Why?
|
Apoptosis | 2 | 2021 | 9511 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2207 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2017 | 663 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2018 | 562 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4472 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2002 | 1622 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5195 | 0.030 |
Why?
|
Immune Evasion | 1 | 2018 | 377 | 0.030 |
Why?
|
Cytokines | 2 | 2020 | 7424 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1731 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2523 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2794 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1332 | 0.030 |
Why?
|
Serum Albumin | 1 | 2016 | 676 | 0.030 |
Why?
|
Phenotype | 3 | 2020 | 16706 | 0.030 |
Why?
|
Benchmarking | 1 | 2019 | 1053 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2538 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2017 | 1070 | 0.030 |
Why?
|
X-Rays | 1 | 2013 | 310 | 0.030 |
Why?
|
Homozygote | 1 | 2017 | 1774 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2409 | 0.020 |
Why?
|
Dermis | 1 | 2013 | 204 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2012 | 26332 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2012 | 311 | 0.020 |
Why?
|
Fluorouracil | 1 | 2017 | 1648 | 0.020 |
Why?
|
Testosterone | 1 | 2002 | 2495 | 0.020 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 2012 | 386 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2002 | 3504 | 0.020 |
Why?
|
Unnecessary Procedures | 1 | 2014 | 416 | 0.020 |
Why?
|
Melphalan | 1 | 2012 | 425 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2261 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2020 | 4255 | 0.020 |
Why?
|
Cell Movement | 1 | 2002 | 5192 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2001 | 5787 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2015 | 1129 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 497 | 0.020 |
Why?
|
Emergency Service, Hospital | 1 | 2009 | 7875 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2013 | 1885 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2017 | 1651 | 0.020 |
Why?
|
Gene Deletion | 1 | 2017 | 2666 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2018 | 2475 | 0.020 |
Why?
|
Hematopoietic Stem Cells | 1 | 2021 | 3406 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3458 | 0.020 |
Why?
|
Dogs | 1 | 2013 | 3822 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2015 | 1394 | 0.020 |
Why?
|
Stem Cells | 1 | 2001 | 3539 | 0.020 |
Why?
|
Urban Health Services | 1 | 2009 | 176 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13403 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14637 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2013 | 5879 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3067 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2020 | 5125 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2012 | 839 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11865 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2009 | 433 | 0.020 |
Why?
|
Hospitals, Urban | 1 | 2009 | 493 | 0.020 |
Why?
|
Thoracotomy | 1 | 2009 | 369 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9245 | 0.020 |
Why?
|
Genome, Human | 1 | 2020 | 4446 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2012 | 2227 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 2018 | 3431 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3623 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2024 | 11641 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2020 | 7599 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2013 | 21053 | 0.020 |
Why?
|
Autoimmune Diseases | 1 | 2018 | 2223 | 0.020 |
Why?
|
Protein Binding | 1 | 2018 | 9299 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9548 | 0.020 |
Why?
|
Glucose | 1 | 2017 | 4334 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2014 | 81457 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39180 | 0.010 |
Why?
|
Gene Expression | 1 | 2017 | 7584 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18289 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12123 | 0.010 |
Why?
|
Models, Biological | 1 | 2020 | 9441 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8732 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8279 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6307 | 0.010 |
Why?
|
Mammography | 1 | 2013 | 2423 | 0.010 |
Why?
|
Pneumonectomy | 1 | 2009 | 1128 | 0.010 |
Why?
|
Patient Admission | 1 | 2009 | 1364 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8876 | 0.010 |
Why?
|
Urban Population | 1 | 2009 | 2040 | 0.010 |
Why?
|
Tissue Transplantation | 1 | 2001 | 128 | 0.010 |
Why?
|
Point-of-Care Systems | 1 | 2009 | 1217 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 2001 | 261 | 0.010 |
Why?
|
Retroviridae | 1 | 2001 | 847 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2779 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2001 | 839 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 65180 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8062 | 0.010 |
Why?
|
Adenoviridae | 1 | 2001 | 1092 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2001 | 2061 | 0.010 |
Why?
|
Neuroglia | 1 | 2001 | 964 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 18061 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3751 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2001 | 2626 | 0.010 |
Why?
|
RNA-Binding Proteins | 1 | 2001 | 1876 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2018 | 36537 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4391 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40066 | 0.000 |
Why?
|